Log in to save to my catalogue

919 Tegavivint reduces the immunosuppressive macrophage phenotype in a preclinical co-culture model...

919 Tegavivint reduces the immunosuppressive macrophage phenotype in a preclinical co-culture model...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7283dcfb3415445fb1c161561fe5a718

919 Tegavivint reduces the immunosuppressive macrophage phenotype in a preclinical co-culture model of the non-small cell lung cancer tumor microenvironment

About this item

Full title

919 Tegavivint reduces the immunosuppressive macrophage phenotype in a preclinical co-culture model of the non-small cell lung cancer tumor microenvironment

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A964-A964

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundActivation of the Wnt/ß-catenin pathway in non-small cell lung cancer (NSCLC) is associated with tumor growth and metastasis. Activation of this pathway in tumor cells may also modulate the immune tumor microenvironment (TME) by polarizing macrophages into an immunosuppressive M2-like phenotype. We tested whether treatment of co-cultures...

Alternative Titles

Full title

919 Tegavivint reduces the immunosuppressive macrophage phenotype in a preclinical co-culture model of the non-small cell lung cancer tumor microenvironment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7283dcfb3415445fb1c161561fe5a718

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7283dcfb3415445fb1c161561fe5a718

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2021-SITC2021.919

How to access this item